Lantheus Holdings Inc

Lantheus Holdings Inc has a market capitalization of $6.14 billion and a price-to-earnings ratio of 26.29, which is above the industry median for medical equipment and supplies firms. The company's liquidity position is characterized by $359.12 million in cash and equivalents, but its long-term debt of $569.42 million results in a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.52 suggests a moderate leverage profile, and the current ratio of 2.7 indicates a strong short-term liquidity position. In terms of profitability, Lantheus reports a return on equity (ROE) of 21.43% and a return on assets (ROA) of 10.49%, both of which are strong relative to the industry median. The company's operating margin is 19.97% (calculated from operating income of $310.83 million on revenue of $1.54 billion), and its net profit margin is 15.15% (calculated from net income of $233.56 million). These metrics suggest that Lantheus is effectively managing its costs and generating solid returns on its capital base. Geographically, Lantheus' revenue is primarily concentrated in the United States, with a significant portion derived from the diagnostic imaging market. The company's exposure to this market is a key driver of its revenue and profitability. There is no detailed breakdown of revenue by geographic region in the provided data, but the company's operations are largely domestic. Looking ahead, Lantheus is projected to maintain a stable growth trajectory, with revenue expected to remain consistent in the current fiscal year and potentially increase in the next fiscal year. The company's capital expenditure of -$36.09 million indicates a reduction in investment in physical assets, which may reflect a focus on optimizing existing operations rather than expanding capacity. The company's free cash flow of $267.57 million provides flexibility for dividends, share repurchases, or further investment in growth opportunities. The risk assessment for Lantheus highlights a medium liquidity risk due to the negative net cash position after accounting for long-term debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's risk profile is further supported by its strong operating cash flow of $390.14 million, which provides a buffer against potential financial stress. Recent events and disclosures indicate that Lantheus has not issued any new shares or engaged in significant capital-raising activities in the near term. The company's financial statements and disclosures do not suggest any immediate plans for equity dilution. The analyst estimates for Lantheus are mixed, with a mean price target of $92.77 and a median price target of $96.00, indicating a range of expectations among analysts.